ASTM F2901

ASTM F2901 is a technical guide for selecting tests used to evaluate the potential neurotoxicity of medical devices. It helps manufacturers, evaluators, and quality teams identify appropriate testing approaches when a device may contact the nervous system or involve materials that could raise neurological safety questions. As a focused ASTM standard, it supports more consistent test selection, better documentation, and a clearer path for assessing risk during product development and regulatory review.

Purpose of ASTM F2901

The purpose of ASTM F2901 is to guide users in choosing tests that are relevant to possible neurotoxic effects associated with medical devices. Rather than defining a single test method, it provides a framework for selecting an appropriate evaluation strategy based on the device and its intended contact or use. This makes the standard especially useful when planning preclinical assessment, comparing test options, or building a rational safety package for a device submission.

Common use cases of ASTM F2901

ASTM F2901 is commonly used during medical device development, biocompatibility planning, and safety review when potential neurotoxicity must be considered. It may be applied to devices, components, or materials where contact with nervous tissue or exposure-related concerns are part of the risk assessment. The standard is also useful for internal testing workflows, supplier qualification, and preparing documentation that explains why certain neurotoxicity tests were selected or not selected.

Why ASTM F2901 matters

This standard matters because test selection affects both patient safety and the efficiency of the evaluation process. ASTM F2901 helps reduce uncertainty by supporting a more consistent, evidence-based approach to neurotoxicity assessment. That can improve quality control, strengthen compliance documentation, and help teams avoid unnecessary testing while still addressing real risk. For procurement and product development, it provides a clear technical reference for comparing evaluation plans and supporting design decisions.

• Guidance for neurotoxicity test selection
• Medical device safety evaluation support
• Risk-based assessment planning
• Preclinical documentation reference
• Consistency in testing decisions